PERSPECTA

News from every angle

Results for "Pancreatic Cancer"

140 stories found

Former Brest Manager Eric Roy Battled Pancreatic Cancer
WorldYahoo2mo ago

Former Brest Manager Eric Roy Battled Pancreatic Cancer

Eric Roy, the former manager of Stade Brestois, passed away at 58 after a three-year private battle with pancreatic cancer, a diagnosis he received the day after taking the Brest job and kept secret from most, including some of his squad.

OpenAI Files for US IPO, Joining Other AI Firms in Public Market Push
BusinessBBCbloombergNYT+43FTle-mondeThe GuardianAl Jazeeradr-dknrkcnbchelsingin-sanomat+35 more2mo ago46 sources

OpenAI Files for US IPO, Joining Other AI Firms in Public Market Push

OpenAI, the company behind ChatGPT, has officially filed for an initial public offering (IPO) in the United States, following in the footsteps of other AI giants like Anthropic. This move signals a growing trend of artificial intelligence companies seeking to enter public markets.

New Pancreatic Cancer Pill Doubles Life Expectancy
Healthnaftemporiki2mo ago

New Pancreatic Cancer Pill Doubles Life Expectancy

A new therapeutic development announced at the American Society of Clinical Oncology (ASCO) conference is being hailed as a revolution in oncology, as it reportedly doubles the life expectancy for patients with metastatic pancreatic cancer from 6.7 to 13.2 months.

Experimental Pill Doubles Pancreatic Cancer Survival Rates
HealthAPBBCThe Guardian+14NPRcnbcaftonbladetdigi24hvgobservadorYahoostraits-times+6 more3mo ago17 sources

Experimental Pill Doubles Pancreatic Cancer Survival Rates

An experimental daily pill has shown promising results in clinical trials, doubling the survival time for patients with pancreatic cancer. This breakthrough offers new hope for treating the deadly disease.

New Vaccine Shows Promise for Pancreatic Cancer Treatment
Healthmorgunbladidnewsbeast3mo ago2 sources

New Vaccine Shows Promise for Pancreatic Cancer Treatment

A new vaccine for pancreatic cancer is showing promising results in clinical trials. Separately, a clinical study for lung cancer, CLIMEDIN, reports improvements in quality of life and reduced care costs for patients.

US Appeals Court Limits Mail-Order Access to Abortion Pill
PoliticsAPReutersBBC+19NYTle-mondeThe GuardianCNNFox Newsnosruvaftonbladet+11 more4mo ago22 sources

US Appeals Court Limits Mail-Order Access to Abortion Pill

A US federal appeals court has temporarily blocked the mail delivery of the abortion pill mifepristone, limiting access to the medication nationwide. This ruling restricts how the pill can be dispensed, pending further legal review.

Pentagon Official States Iran War Cost Reaches $25 Billion
WorldAPbloombergNYT+56Al Jazeeradr-dkcnbcukrainska-pravdaDWle-figaroSCMPFrance 24+48 more4mo ago59 sources

Pentagon Official States Iran War Cost Reaches $25 Billion

A Pentagon official has revealed that the United States' involvement in the war in Iran has cost $25 billion so far. This figure represents the financial expenditure over approximately two months of conflict.

New Drug Doubles Survival for Pancreatic Cancer Patients
Healthla-vanguardia4mo ago

New Drug Doubles Survival for Pancreatic Cancer Patients

A new targeted therapy against RAS proteins has shown to double the survival rate for pancreatic cancer patients, marking a significant breakthrough in the treatment of the disease. RAS proteins are responsible for over 90% of pancreatic cancer cases.

Two mistakes. Patient died, doctor accused
Healthtvn245mo ago

Two mistakes. Patient died, doctor accused

A radiologist's error may have contributed to the death of a patient with pancreatic cancer, the Regional Prosecutor's Office in Łódź assessed and filed an indictment with the court.

U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
HealthBBCNYTNPR+8globe-and-maillsm-lvYahoobalkan-webnewsbeastThe Weektaiwan-newsmyjoyonline5d ago11 sources

U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates

The U.S. Food and Drug Administration has approved a breakthrough pancreatic cancer treatment that clinical trials show extends patient survival to a median of 13.2 months, marking a major advancement for one of the most difficult-to-treat cancers.

FDA Approves Breakthrough Pancreatic Cancer Pill That Nearly Doubles Survival Rates
HealthAPReutersBBC+40NYTwsjle-mondewapoThe GuardianCNNFox Newscnbc+32 more5d ago43 sources

FDA Approves Breakthrough Pancreatic Cancer Pill That Nearly Doubles Survival Rates

The U.S. Food and Drug Administration has approved a new once-daily oral medication for advanced pancreatic cancer, marking a significant clinical breakthrough that nearly doubled patient survival rates in trials. The approval has prompted analysts to raise price targets for associated biotechnology firms.

New Cancer Treatments Unveiled at US Conference
HealthThe Guardian2mo ago

New Cancer Treatments Unveiled at US Conference

Doctors, scientists, and researchers shared new advancements in cancer treatment at the 2026 Asco conference, including drugs that target cancer cells' ability to hide and breakthroughs for pancreatic cancer.

New Drug Shows Promise in Pancreatic Cancer Treatment
Healthtelextvn24observador+3indian-expressdanasnewsbeast3mo ago6 sources

New Drug Shows Promise in Pancreatic Cancer Treatment

A new drug for pancreatic cancer has shown significant potential, with scientists reporting it could nearly double the survival rate for patients. This breakthrough was met with a standing ovation at an oncology conference, marking a potential turning point in treatment.

Experimental Drug Hailed as Breakthrough for Pancreatic Cancer, Doubling Survival Time
Healthcbcmarketwatchn1-serbia3mo ago3 sources

Experimental Drug Hailed as Breakthrough for Pancreatic Cancer, Doubling Survival Time

A new experimental drug that nearly doubles the survival time for patients with pancreatic cancer, extending it from six and a half months to 13 months, has been hailed as a significant breakthrough. The announcement of this successful late-stage treatment brought an audience of doctors and global oncology professionals to their feet.

Italian actress, TV presenter Enrica Bonaccorti dies aged 76
CultureANSA5mo ago

Italian actress, TV presenter Enrica Bonaccorti dies aged 76

(ANSA) - ROME, MAR 12 - Italian actress and TV and radio presenter Enrica Bonaccorti has died at the age of 76, Clemente Mimun, the director of Mediaset's Tg5 news, said via X on Thursday. A versatile artist, she was a big TV star in the 1980s, although she also enjoyed success in the theatre and cinema. She had been diagnosed with pancreatic cancer less than two years ago and, after a period of silence, she talked about her treatment in interviews and on social media. (ANSA). Read article...

Pancreatic Cancer Vaccine Shows Positive Results in Trials
Worldel-mundoobservador1mo ago2 sources

Pancreatic Cancer Vaccine Shows Positive Results in Trials

A new vaccine designed to prevent pancreatic cancer has shown positive results in trials, offering hope for high-risk individuals. Researchers are developing this vaccine to target and potentially prevent the aggressive disease.

Advances in Pancreatic Cancer Treatment in Romania
Healthhotnews1mo ago

Advances in Pancreatic Cancer Treatment in Romania

New surgical techniques, including robotic interventions and complex vascular resections, are improving the chances for pancreatic cancer patients in Romania, as highlighted by Dr. Augustin Dima at Băneasa Tumor Center.

Brest Manager Eric Roy Dies at 58
HealthYahoo2mo ago

Brest Manager Eric Roy Dies at 58

Eric Roy, the manager of Brest and former Sunderland midfielder, has died at the age of 58 after a three-and-a-half year battle with pancreatic cancer.

New Drug Study Offers Hope for Pancreatic Cancer Treatment
Healthiefimeridanewsbeast2mo ago2 sources

New Drug Study Offers Hope for Pancreatic Cancer Treatment

A new study on a pancreatic cancer treatment is being hailed as a revolution in oncology, offering a new hopeful therapeutic development. Experts from EKPA (National and Kapodistrian University of Athens) are highlighting the potential of this new drug.

New Experimental Drug Shows Promise Against Pancreatic Cancer
Healthder-standard3mo ago

New Experimental Drug Shows Promise Against Pancreatic Cancer

A new experimental drug has reportedly doubled the average survival time for individuals with pancreatic cancer, extending it from six and a half months to 13 months. This development offers new hope in the fight against one of the deadliest forms of cancer.

New Pancreatic Cancer Drug Doubles Survival Rate
Healthle-mondedaily-mirror-lk3mo ago2 sources

New Pancreatic Cancer Drug Doubles Survival Rate

An international trial presented at the American Society of Clinical Oncology congress revealed that a new drug, daraxonrasib, significantly increases survival rates for patients with metastatic pancreatic tumors, with France also rolling out a prevention program.

Healthbloombergstraits-times4mo ago2 sources

AI Detects Pancreatic Cancer Years Before Symptoms Emerge

A recent study has revealed that artificial intelligence can identify signs of pancreatic cancer years before the disease typically manifests symptoms. This breakthrough could significantly improve early detection and treatment outcomes for patients.